Wenfeng Xu

8.5k total citations · 3 hit papers
43 papers, 3.8k citations indexed

About

Wenfeng Xu is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Wenfeng Xu has authored 43 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Wenfeng Xu's work include Plant-Microbe Interactions and Immunity (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Genomics and Phylogenetic Studies (5 papers). Wenfeng Xu is often cited by papers focused on Plant-Microbe Interactions and Immunity (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Genomics and Phylogenetic Studies (5 papers). Wenfeng Xu collaborates with scholars based in China, United States and United Kingdom. Wenfeng Xu's co-authors include Earl W. Davie, Henrik Andersen, Donald C. Foster, Theodore E. Whitmore, Teresa Gilbert, Scott Presnell, Andrew Ching, David P. Yee, Harald S. Haugen and Julia Parrish-Novak and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Wenfeng Xu

41 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

2000 967 citations Jane A. Gross, Janet Johnston et al. Nature profile →
Cloning and characterization of human protease-activated receptor 4

1998 701 citations Wenfeng Xu, Henrik Andersen et al. Proceedings of the National Academy of Sciences profile →
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

2009 526 citations Cameron S. Brandt, Myriam Baratin et al. The Journal of Experimental Medicine profile →

Peers

Countries citing papers authored by Wenfeng Xu

Since Specialization

Citations

This map shows the geographic impact of Wenfeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenfeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenfeng Xu more than expected).

Fields of papers citing papers by Wenfeng Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenfeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenfeng Xu. The network helps show where Wenfeng Xu may publish in the future.

Co-authorship network of co-authors of Wenfeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenfeng Xu. A scholar is included among the top collaborators of Wenfeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenfeng Xu. Wenfeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of a rapid 17β-estradiol-degrading strain, Microbacterium proteolyticum ZJSU01 2025 ·Applied Microbiology and Biotechnology ·Yipeng Chen, Ting Chen, Wenfeng Xu, Xiaoqin Yu, Xiujuan Tang, Shurui Wang, Jun Yin	0
2	A multi-omics study reveals the therapeutic effect of Linderae Radix water extract on irritable bowel syndrome (IBS-D) 2024 ·Journal of Ethnopharmacology ·(unknown), Tao Liu, (unknown), (unknown), Wenfeng Xu, (unknown), (unknown), (unknown), (unknown), Xiaohe Xiao	4
3	Epithelioid Subtype Gastrointestinal Stromal Tumors of Stomach in an Endoscopic Biopsy: A Potential Diagnostic Pitfall 2023 ·OncoTargets and Therapy ·Wenfeng Xu, (unknown), (unknown), (unknown), (unknown), Yujuan Xu, Deyu Guo	0
4	The Cardiorespiratory fitness of children and adolescents in Tibet at altitudes over 3,500 meters 2021 ·PLoS ONE ·(unknown), (unknown), (unknown), Mei Wang, (unknown), Qiang Feng, Wenfeng Xu, (unknown), (unknown), (unknown), Jingjing Wang	12
5	Enrichment of circulating tumor-derived extracellular vesicles from human plasma 2020 ·Journal of Immunological Methods ·(unknown), Christopher J. Lowe, Shilpi Mahajan, (unknown), (unknown), Mike Reichelt, Jenny J. Yang, (unknown), Yijin Li, Luciana Molinero, Jane Ruppel, Wenfeng Xu, Vicki Plaks	27
6	<p>Inhibition of Aurora Kinase A by Alisertib Reduces Cell Proliferation and Induces Apoptosis and Autophagy in HuH-6 Human Hepatoblastoma Cells</p> 2020 ·OncoTargets and Therapy ·Jingyi Tan, Wenfeng Xu, Lei Lei, Hui Liu, Hong Wang, Xian Cao, Man Xu	9
7	Comparative genomic analysis of Bacillus paralicheniformis MDJK30 with its closely related species reveals an evolutionary relationship between B. paralicheniformis and B. licheniformis 2019 ·BMC Genomics ·Yuhui Du, Jinjin Ma, Zhiqiu Yin, Kai Liu, (unknown), Wenfeng Xu, (unknown), Binghai Du, Yanqin Ding, Chengqiang Wang	42
8	HIF1α deletion facilitates adipose stem cells to repair renal fibrosis in diabetic mice 2018 ·In Vitro Cellular & Developmental Biology - Animal ·Qun Tang, Hua Wu, (unknown), Chun Yi, Wenfeng Xu, (unknown), (unknown), Chunyan Liu	5
9	Cutting Edge: Identification of Neutrophil PGLYRP1 as a Ligand for TREM-1 2015 ·The Journal of Immunology ·(unknown), Joseph L. Kuijper, Siv A. Hjorth, Mark Heipel, Xiaoting Tang, Andrew J. Fleetwood, (unknown), S. Grell, Jesper Kastrup, (unknown), Cameron S. Brandt, Anker Jón Hansen, Nicolai Wagtmann, Wenfeng Xu, (unknown)	122
10	The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans breakdown → 2009 ·The Journal of Experimental Medicine ·Cameron S. Brandt, Myriam Baratin, Eugene C. Yi, Jacob J. Kennedy, Zeren Gao, Brian A. Fox, Betty Haldeman, (unknown), Tomonori Kaifu, Christian Chabannon, Alessandro Moretta, Robert West, Wenfeng Xu, Éric Vivier, Steven D. Levin	526
11	Prospective comparison of five mediators of the systemic response after high‐intensity focused ultrasound and targeted cryoablation for localized prostate cancer 2009 ·British Journal of Urology ·Li Ling, Ming Yang, Xin Gao, (unknown), (unknown), Wenfeng Xu, Zhe Lin, (unknown)	9
12	IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not 2009 ·Journal of Molecular Medicine ·Kerstin Wolk, Harald S. Haugen, Wenfeng Xu, Ellen Witte, Kim Waggie, (unknown), Elmar vom Baur, Katrin Witte, Katarzyna Warszawska, Sandra Philipp, Caroline Johnson‐Léger, Hans‐Dieter Volk, Wolfram Sterry, Robert Sabat	348
13	Urinary fibronectin as a predictor of a residual tumour load after transurethral resection of bladder transitional cell carcinoma 2008 ·British Journal of Urology ·Li Ling, Ming Yang, (unknown), (unknown), Wenfeng Xu, Yong Chen, Zhoujun Shen, Xin Gao	10
14	Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans 2007 ·Proceedings of the National Academy of Sciences ·Serpil C. Erzurum, Sudipta Ghosh, Anna Janocha, Wenfeng Xu, Selena Bauer, Nathan S. Bryan, Jesús Tejero, Craig Hemann, Russ Hille, Dennis J. Stuehr, Martin Feelisch, Cynthia M. Beall	278
15	Interleukins 19, 20, and 24 Signal through Two Distinct Receptor Complexes 2002 ·Journal of Biological Chemistry ·Julia Parrish-Novak, Wenfeng Xu, Ty Brender, Lena Yao, (unknown), Jim West, Cameron S. Brandt, (unknown), (unknown), Patricia A. McKernan, Donald C. Foster, Stephen R. Jaspers, Yasmin A. Chandrasekher	231
16	TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease breakdown → 2000 ·Nature ·Jane A. Gross, Janet Johnston, Sherri Mudri, (unknown), Stacey R. Dillon, (unknown), Wenfeng Xu, Julia Parrish-Novak, Don Foster, (unknown), Margaret Moore, (unknown), (unknown), Harald S. Haugen, Kevin P. Foley, Hal Blumberg, (unknown), Wayne Kindsvogel, Christopher H. Clegg	967
17	Molecular Cloning of Human ABPL, an Actin-Binding Protein Homologue 1998 ·Biochemical and Biophysical Research Communications ·(unknown), Wenfeng Xu, Earl W. Davie, Dominic W. Chung	62
18	A Novel Human Actin-Binding Protein Homologue That Binds to Platelet Glycoprotein Ib 1998 ·Blood ·Wenfeng Xu, (unknown), Dominic W. Chung, Earl W. Davie	5
19	Cloning and characterization of human protease-activated receptor 4 breakdown → 1998 ·Proceedings of the National Academy of Sciences ·Wenfeng Xu, Henrik Andersen, Theodore E. Whitmore, Scott Presnell, David P. Yee, Andrew Ching, Teresa Gilbert, Earl W. Davie, Donald C. Foster	701
20	A Novel Human Actin-Binding Protein Homologue That Binds to Platelet Glycoprotein Ib 1998 ·Blood ·Wenfeng Xu, (unknown), Dominic W. Chung, Earl W. Davie	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact